Global Status of Commercialized Biotech/GM Crops in 2017: Biotech Crop Adoption Surges as Economic Benefits Accumulate in 22 Years

ISAAA Brief 53-2017

Price:  $ 50.00

 
Description: Biotech crops in the last 22 years of commercialization have brought immense economic benefits, health improvement and social gains which should be shared with the global community. Accurate information on the benefits and potentials of biotech crops will allow farmers and consumers to make informed-choice in what crops to grow and consume, respectively; policy makers and regulators to craft enabling biosafety guidelines for commercialization and adoption of biotech crops; and science communicators and the media to facilitate dissemination of the benefits and potentials of the technology.
Published by: ISAAA
Copyright: ISAAA
Correct citation: "ISAAA. 2017. Global Status of Commercialized Biotech/GM Crops in 2017: Biotech Crop Adoption Surges as Economic Benefits Accumulate in 22 Years. ISAAA Brief No. 53. ISAAA: Ithaca, NY."
ISBN: 978-1-892456-67-2
 
100 in stock
SHIPPING CHARGES WILL BE ADDED
[View webpage][Download PDF]